Urology Doctor | Mitchell D. Efros MD FACS

Dr. Mitchell Efros, MD

Claim this profile

AccuMed Research Associates

Studies Transitional Cell Carcinoma
Studies Bladder Cancer
5 reported clinical trials
6 drugs studied

Area of expertise

1

Transitional Cell Carcinoma

Mitchell Efros, MD has run 3 trials for Transitional Cell Carcinoma. Some of their research focus areas include:

Stage II
Stage I
2

Bladder Cancer

Mitchell Efros, MD has run 3 trials for Bladder Cancer. Some of their research focus areas include:

Stage II
Stage I

Affiliated Hospitals

Image of trial facility.

Accumed Research Associates

More about Mitchell Efros, MD

Clinical Trial Related

1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Mitchell Efros, MD has experience with

  • UGN-102
  • AMDC-USR (iltamiocel)
  • Placebo
  • TURBT
  • Viveve Treatment
  • UGN-103

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Mitchell Efros, MD specialize in?

Is Mitchell Efros, MD currently recruiting for clinical trials?

Are there any treatments that Mitchell Efros, MD has studied deeply?

What is the best way to schedule an appointment with Mitchell Efros, MD?

What is the office address of Mitchell Efros, MD?

Is there any support for travel costs?